Microbial infection and inflammation in the development of chronic lung disease of prematurity

Ying-Hua Li1, Kjell Tullus

  • 1Astrid Lindgren Children's Hospital, Karolinska Institutet, SE-17176 Stockholm, Sweden.

Insights

Bronchopulmonary dysplasia, a lung disease in premature infants, stems from complex causes including infections and inflammation. This review explores the molecular pathways driving its development in vulnerable newborns.

Area of Science:

  • Neonatal Medicine
  • Pulmonology
  • Developmental Biology

Background:

  • Bronchopulmonary dysplasia (BPD), also known as chronic lung disease of prematurity, affects very low birth-weight neonates.
  • It is characterized by prolonged respiratory failure with a multifactorial etiology.
  • Understanding the underlying mechanisms is crucial for improving outcomes.

Purpose of the Study:

  • To review current knowledge on the molecular mechanisms of BPD.
  • To elucidate the roles of infections and inflammatory responses in BPD development.
  • To provide a comprehensive overview for researchers and clinicians.

Main Methods:

  • Literature review of existing research on BPD.
  • Analysis of molecular pathways involved in neonatal lung injury.
  • Synthesis of data on infectious and inflammatory triggers.

Main Results:

  • Identified key molecular signaling pathways implicated in BPD pathogenesis.
  • Highlighted the significant contribution of specific infections to lung inflammation.
  • Detailed the inflammatory cascades leading to chronic lung disease.

Conclusions:

  • Infections and inflammatory responses are critical drivers of BPD.
  • Targeting these molecular mechanisms may offer therapeutic strategies.
  • Further research into the complex etiology of BPD is warranted.

Related Concept Videos

Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...